Supaverm Oral Suspension

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Closantel, Mebendazole

Available from:

Eli Lilly and Company Limited

ATC code:

QP52A

INN (International Name):

Closantel, Mebendazole

Pharmaceutical form:

Oral suspension

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Sheep

Therapeutic area:

Anthelmintic flukicide

Authorization status:

Authorized

Authorization date:

1988-04-11

Summary of Product characteristics

Revised: June 2013
AN: 00229/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Supaverm Oral Suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
% w/v
Closantel (as closantel sodium dihydrate)
5
Mebendazole
7.5
EXCIPIENTS:
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Suspension
White to faintly cream coloured suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep and lambs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of fascioliasis (due to _Fasciola hepatica_) and
gastrointestinal
nematodes and cestodes in sheep and lambs. The combination is active
against
lungworm, roundworms, tapeworms (heads and segments) and fluke (mature
and
immature).
For the control of the larval stages of_ Oestrus ovis _(Sheep Nasal
Bot fly).
For the control of inhibited, immature and adult stages of _Haemonchus
contortus_
(Barber Pole worm) including benzimidazole resistant strains.
Also effective against benzimidazole susceptible strains of the
following:
GASTRO-INTESTINAL ROUNDWORMS: _Ostertagia_ spp, _Trichostrongylus_
spp,
_Nematodirus_ spp, _Cooperia_ spp, _Oesophagostomum_ spp, _Chabertia
ovina, _
_Bunostomum_ spp, _Trichurus ovis_, _Strongyloides papillosus_.
LUNGWORM: _Dictyocaulus_ _filaria_
TAPEWORM: _Moniezia_ spp.
Page 1 of 6
Revised: June 2013
AN: 00229/2012
_Fluke activity:_
_Stage_
_Percentage kill _
Adults
97-100 %
6-8 weeks immature
91-95 %
5 weeks immature
91 %
3-4 weeks immature
23-73 %
Ticks (_Ixodes ricinus_) feeding on sheep at the time of treatment are
likely to
produce fewer viable eggs.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the
risk of development of resistance and could ultimately result in
ineffective
therapy:

Too frequent and repeated use of anthelmintics from the same class,
over an extended period of time.

Underdosing, which may be due to underestimation of body weight,
misadminist